Benefits and risks preferences for new medicines in rare diseases - On Biology

Benefits and risks preferences for new medicines in rare diseases - On Biology

On Biology

 

Benefits and risks preferences for new medicines in rare diseases

Orphanet Journal of Rare Diseases has recently published an article quantifying the benefit-risk preferences for new medicines in rare disease patients and caregivers. Editor-in-Chief for the journal Ségolène Aymé discusses this publication fur